Tech Company Financing Transactions

Novelion Therapeutics Funding Round

Novelion Therapeutics closed a $22 million Series A financing round on 6/14/2006. Backers included Advent International, Alta Partners and Index Ventures.

Transaction Overview

Announced On
6/14/2006
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Series A
Investors

Advent International (Lead Investor) (Jason Fisherman)

Alta Partners

Index Ventures

Proceeds Purpose
Proceeds will fund Phase II development of its lead dyslipidemia drug, AEGR 733.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
510 West Georgia St. 1800
Vancouver BC, V6B 0M3
USA
Email Address
Overview
Novelion Therapeutics is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.
Profile
Novelion Therapeutics LinkedIn Company Profile
Social Media
Novelion Therapeutics Company Twitter Account
Company News
Novelion Therapeutics News
Facebook
Novelion Therapeutics on Facebook
YouTube
Novelion Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sandford Smith
  Sandford Smith LinkedIn Profile  Sandford Smith Twitter Account  Sandford Smith News  Sandford Smith on Facebook
Chief Financial Officer
Michael Price
  Michael Price LinkedIn Profile  Michael Price Twitter Account  Michael Price News  Michael Price on Facebook
Chief Operating Officer
Jeffrey Hackman
  Jeffrey Hackman LinkedIn Profile  Jeffrey Hackman Twitter Account  Jeffrey Hackman News  Jeffrey Hackman on Facebook
VP - General Counsel
Ben Harshbarger
  Ben Harshbarger LinkedIn Profile  Ben Harshbarger Twitter Account  Ben Harshbarger News  Ben Harshbarger on Facebook
VP - Human Resources
Linda Buono
  Linda Buono LinkedIn Profile  Linda Buono Twitter Account  Linda Buono News  Linda Buono on Facebook
VP - R & D
Murray Stewart
  Murray Stewart LinkedIn Profile  Murray Stewart Twitter Account  Murray Stewart News  Murray Stewart on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/13/2006: Oddcast venture capital transaction
Next: 6/14/2006: Aveksa venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on funding rounds that are announced publicly. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary